Table 1.

Patient characteristics.

Characteristic	All patients (N=503)
Demographic information
Age (years) at GB diagnosis, mean (SD)	58.4 (11.8)
Male, n (%)	345 (68.6)
Race and ethnicity, n (%)
White	372 (74.0)
Black or African–American	83 (16.5)
Asian	22 (4.4)
Hispanic or Latino	12 (2.4)
Othera	14 (2.8)
Marital status, n (%)
Married	360 (71.6)
Single	109 (21.7)
Not known	34 (6.8)
GB type, n (%)
Primary	492 (97.8)
Secondary	11 (2.2)
Primary site of GB tumor, n (%)
Frontal	147 (29.2)
Parietal	202 (40.2)
Occipital	53 (10.5)
Temporal	78 (15.5)
Unknown and other	23 (4.6)
Charlson Comorbidity Indexb before and at the diagnosis, mean (SD)	0.65 (1.2)
Comorbidities, n (%)c
Hypertension	163 (32.4)
Depression	66 (13.1)
Anxiety	58 (11.5)
Diabetes mellitus without chronic complications	47 (9.3)
Chronic pulmonary disease	38 (7.6)
Peptic ulcer disease	35 (7.0)
Obesity	32 (6.4)
Myocardial infarction	31 (6.2)
Employment status at the diagnosis, n (%)
Full-time	183 (36.4)
Part-time	83 (16.5)
Not employed	205 (40.8)
Unknown	32 (6.4)
Health insurance plan at the diagnosis, n (%)
Private health insurance	263 (52.3)
Medicare	170 (33.8)
Medicaid	57 (11.3)
Uninsured/other	13 (2.6)
Patient has a primary caregiver, n (%)
Primary caregiver present	361 (71.8)
No primary caregiver	100 (19.9)
Unknown	42 (8.3)
Relationship to primary caregiver, n (%)
Spouse	270 (53.7)
Child	40 (8.0)
Extended family relative	34 (6.8)
Not a family member/unknown	17 (3.4)

^aAmerican Indian or Alaska Native, Native Hawaiian or other Pacific Islander, and other.

^bMetastatic solid tumors were not included. Comorbidities were included if they were recorded by the physician as occurring at any time before the diagnosis of GB.

^cComorbidities with >5% occurrence are listed. BMI, body mass index; GB, glioblastoma.